Medicine & Health

Researchers at Washington University School of Medicine, working in mice, have found that a molecule previously linked to diabetes, cancer and muscle atrophy also seems to be involved in the development of osteoarthritis. It may offer a useful treatment target.

Researchers at Washington University School of Medicine in St. Louis have received a five-year $3.2 million grant to study the genetic basis of the musculoskeletal disorder scoliosis, and particularly how it affects African Americans and other underrepresented minorities.

Seven faculty members at Washington University in St. Louis are among 489 new fellows selected by the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society.

Jeffrey Zacks’s latest research turns on its head some popular beliefs about memory, showing that a failed prediction isn’t simply a failure, but also a cue which can help people update their understanding — as long as they realize their prediction was wrong.

The number of confirmed COVID-19 cases are likely to increase to 20 million by the end of January, nearly doubling the current level of 11.4 million cases, predicts a Washington University in St. Louis COVID-19 forecasting model.

Washington University’s Mentored Training for Dissemination and Implementation Research in Cancer program, the first of its kind in cancer prevention and control, has resulted in an uptick in skills, grants, publications, networking and even some practice changes.

School of Medicine researchers have received a grant allowing them to offer 50,000 saliva tests for the SARS-CoV-2 virus to students, teachers and staff in the six special education schools operated by the Special School District of St. Louis County.

School of Medicine scientists have identified a molecule that protects mice from brain infections caused by Venezuelan equine encephalitis virus, a mosquito-borne virus notorious for causing fast-spreading, deadly outbreaks in Mexico, Central America and northern South America.

A study led by School of Medicine researchers showed that, contrary to expectations, most people with severe COVID-19 do not suffer from unbridled inflammation. The findings suggest that anti-inflammatory therapies may not be helpful for most COVID-19 patients.

Researchers at Washington University School of Medicine have found that the drug fluvoxamine may help prevent deterioration in COVID-19 patients, making hospitalization less likely.